VedaBio innovative platform for near-instant molecular detection.
VedaBio has raised $25.0M in total funding. The most recent round was Series A. The last funding was announced in September 2025.
VedaBio's investors include Siemens Healthineers, OMX Ventures, Kleinmuntz Associates.
VedaBio is headquartered in San Diego, United States.
VedaBio innovative platform for near-instant molecular detection.
VedaBio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"VedaBio — Funding & Investors." VCBacked, September 23, 2025, https://www.vcbacked.co/company/vedabio. Accessed August 1, 2026.
VCBacked. (2025). VedaBio — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/vedabio
{{cite web |title=VedaBio — Funding & Investors |url=https://www.vcbacked.co/company/vedabio |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated